Durapain in symptomatic treatment of severe acute pain: a post-marketing, prospective, multicenter, observational study – PRIME study

OBJECTIVE: To assess the effectiveness, overall tolerability, and gastrointestinal (GI) tolerability of Durapain (fixed dose combination of tramadol hydrochloride immediate release [50 mg] and diclofenac sodium sustained release [75 mg]) in symptomatic treatment of severe acute pain in physician’s r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Kshitij, Chaudhari, Omvijay B, Gupta, Palash, Chaudhuri, R Hom, Kamilya, Ranjan, Kulkarni, Shreedhar S, Subbaiah, S, Sorathia, Zubair H, Billa, Gauri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449136/
https://www.ncbi.nlm.nih.gov/pubmed/28579825
http://dx.doi.org/10.2147/JPR.S123772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449136/
https://www.ncbi.nlm.nih.gov/pubmed/28579825
http://dx.doi.org/10.2147/JPR.S123772

Ejemplares similares